Avalon GloboCare sells $400,000 of Series F preferred stock, grants options to executives

Avalon GloboCare Corp. entered into a securities purchase agreement on June 30, 2026 with an accredited investor, Allen O. Cage Jr., under which the company agreed to sell 400 shares of Series F Convertible Preferred Stock, with a stated value of $1,000.00 per share, along with 200,000 shares of common stock as additional consideration, for an aggregate purchase price of $400,000.00¹. The Series F Preferred Stock is convertible into common stock at a conversion price of $0.50 per share.¹ The transaction closed on July 2, 2026.¹

The Series F Preferred Stock is subject to mandatory redemption of 25% of the then outstanding shares on each of October 1, 2026, November 1, 2026, December 1, 2026 and January 1, 2027, at a redemption price per share equal to 125% of the stated value, though holders may elect to convert shares subject to redemption into common stock before the applicable date.¹ Conversion is subject to a beneficial ownership limitation of 4.99% of outstanding common stock.¹

On June 29, 2026, the company also granted three-year stock options under its 2026 Equity Plan. Options to purchase 400,000 shares went to Luisa Ingargiola, Chief Strategy Officer, options to purchase 400,000 shares went to Meng Li, interim Chief Executive Officer, and options to purchase 350,000 shares went jointly to Brio Financial and Sam Knipper, Chief Financial Officer, as consideration for services rendered, with an exercise price of $0.2820 per share.¹ The company separately issued options to purchase 600,000 shares to its non-employee directors at the same exercise price.¹

The company filed a Certificate of Designation for the Series F Preferred Stock with Delaware on July 2, 2026, designating 5,000 authorized shares of Series F Preferred Stock, of which 400 shares were issued as of the original issue date.¹